Eagle Bay Advisors LLC Vectiv Bio Holding Ag Transaction History

Eagle Bay Advisors LLC

$163 Million
Q2 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Jan 21, 2022	SELL	$2.83 - $7.26 $566 - $1,452	-200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.7 - $11.54 $670 - $1,154	100 Added 100.0%	200 $2,000
Q2 2021 Jul 30, 2021	BUY	$11.66 - $24.23 $1,166 - $2,423	100 New	100 $2,000

Others Institutions Holding VECT

# of Institutions

1

Shares Held

510K

Call Options Held

0

Put Options Held

0

Regency Capital Management Inc.\De

510K
Shares

$0
0.0% of portfolio

About VectivBio Holding AG

Ticker VECT
Exchange NASDAQ
Description
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...

More about VECT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.